Daily pills and frequent clinic visits are a major barrier to infectious diseases prevention and treatment, especially in low- and middle-income countries (LMICs). Long-acting technologies (LATs), including injectables, implants, pills, and microneedle patches also known as microarray patches (MAPs), can reduce pill burden, frequency of clinic visits and the costs of repeated travel to health facilities. Long-acting cabotegravir is already recommended by the World Health Organization (WHO) for HIV prevention, and the pipeline is growing for TB, malaria, hepatitis C and more.
TAG, alongside the Long-acting Technologies Community Advisory Board (LAT CAB), is excited to present an upcoming webinar: Beyond Daily Dosing: Exploring the Future of Long-Acting Technologies for Infectious Diseases Control on Thursday, November 12, at 9:00 a.m. EST/ 7:30 p.m. IST/ 11:00 a.m. BRT/ 3:00 p.m. WAT.
During this webinar, speakers will discuss how LATs work, the emerging pipeline for diseases that disproportionately affect LMICs, and what it will take to move these products from research to routine use, including affordability, regulation, procurement and health-system readiness. Community representatives will share experiences from the rollout of long-acting technologies in Zimbabwe and India. The webinar will also introduce microarray patches, an emerging platform for delivering long-acting medicines and vaccines.
Register here: https://us06web.zoom.us/webinar/register/WN_EQS60Y9aQKqchVHy7KUf1w
Facilitators:
Joelle Dountio, Acting HCV Project Director, TAG
Dorothy Onyango, Executive Director, Women Fighting AIDS in Kenya
Speakers:
- Huub Gelderblom (USA), Physician-Scientist, HIV Vaccine Trials Network
- Imelda Mahaka (Zimbabwe), Country Director, Pangaea Zimbabwe AIDS Trust
- Manoj Pardesi (India), General Secretary, National Coalition of People Living with HIV in India
- Hannah Wellington (South Africa), PhD Researcher, Wits Advanced Drug Delivery Platform
- Bakyt Myrzaliev (Kyrgyzstan), Public health and TB Technical Advisor, KNCV Public Foundation, Kyrgyzstan